Introduction {#sec1}
============

Diabetes mellitus is a global health burden; the number of people affected by the disease is expected to rise from the current 285 million to 438 million by the year 2030.[@bib1]

Diabetes mellitus is a lifelong condition that represents a major health problem; it imposes an enormous emotional and financial burden on the patient and the whole community.[@bib2] Due to the adoption of diets with high saturated fat and refined sugar, coupled with a lack of physical activity, diabetes mellitus is emerging as a significant health problem in Sudan. According to the World Health Organization report, half a million people were affected by diabetes in Sudan in the year 2000, and the number is projected to reach one million by the year 2030.[@bib3]

The American Diabetes Association recommendations call for a target for glycated haemoglobin of \<7 in both type 1 and type 2 diabetes mellitus to reduce microvascular complications such as retinopathy, nephropathy, and neuropathy.[@bib4]

There is an increasing awareness of the psychological effects of diabetes self-management and diabetes control and the emotional burden of carrying a diagnosis of diabetes mellitus. Being diagnosed with diabetes is a stressful life condition that requires both physical and mental coping strategies. Depression is common among Sudanese patients with diabetes mellitus, and when present together, these conditions exacerbate one another and can lead to deleterious consequences or even fatal complications.[@bib5]

Psychological stressors, by activating the hypothalamic--pituitary--adrenal axis, can stimulate the sympathetic nervous system, release inflammatory markers, and increase platelet aggregation. This leads to insulin resistance, thereby contributing to poor glycaemic control and increasing the risk of vascular complications.[@bib6]

Diabetes distress captures the fear, worries, and concerns among patients suffering from a chronic, progressive and demanding disease such as diabetes mellitus. Major depressive disorder requires the presence of five out of nine well-defined symptoms that lead to significant functional impairment and emotional distress. The symptoms must be present for at least two weeks.[@bib7], [@bib8]

Diabetes distress differ from depression in the following: It implies aetiology rather than focussing on the presence or absence of specific symptoms, diabetes distress is content related and distinguishes between different causes so that appropriate intervention can be implemented, and diabetes distress is not necessarily considered a co-morbid or psychopathology but, rather, is a reaction to a demanding chronic disorder such as diabetes.[@bib7]

Few researchers have studied the relationship between depression, diabetes distress, and glycaemic control in Sudan. Sudan is a vast country with ethnic and cultural diversity, so the effect of diabetes distress and psychopathology on diabetes mellitus observed in Western countries may not apply. Therefore, we conducted this research to assess the effects of depression and diabetes distress on glycaemic control in Sudan.

Materials and Methods {#sec2}
=====================

This is a cross-sectional descriptive study involving 89 patients with a diagnosis of type 2 diabetes mellitus according to the American Diabetes Association guidelines[@bib4] who were seen for routine follow-up and 29 age- and sex-matched control subjects (used as controls for psychopathology). The study was conducted at a diabetes centre in Omdurman, Sudan, during the period of June 2016 to September 2016. The sample size was calculated using the formula n = Z^2^ P−Q/d^2^ where Z = 95% confidence (1.96), P = Prevalence of diabetes mellitus in Sudan,[@bib9] Q = 100-prevalence, and d = tolerated error. The sample size was calculated to be 76 and increased to 89 to minimize error. The control subjects were randomly chosen from relatives and co-patients to address confounding factors such as socio-economic factors and education level[@bib10]

The participants were asked to sign a written informed consent and were then interviewed in a ratio of 1:2 using a structured questionnaire based on the English versions of the diabetes stress scale and the general health questionnaire-12. The questionnaires were translated into Arabic by experienced translators and the principal researcher. Co-patients explained any difficulties that arose during the interview to ensure that every question was clear to the participants. Patients aged above 35 years with type 2 diabetes were approached in a ratio of 1:1 and those with severe diabetes complications, psychosis, or dementia were excluded. The diabetes distress scale is a well-validated 17-item questionnaire[@bib11] that measures different stressors. Each question has six answer choices: 1 = no problem, 2 = slight problem, 3 = moderate problem, 4 = somewhat serious problem, 5 = a serious problem and 6 = a very serious problem. The questionnaire is further divided into four subscales as follows:•Questions 1, 3, 8, 11, and 14 (emotional burden)•Questions 2, 4, 9, and 15 (physician-related)•Questions 5, 6, 10, 12, and 16 (regimen related)•And questions 7, 13, and 17 (interpersonal relationship)

The cut-off value for the diagnosis of diabetes distress was a sum of ≥three on the scale.[@bib12]

The 12-item general health questionnaire was used for the diagnosis of psychopathology. It is well validated[@bib13] for the measurement of depression in diabetic patients and is widely used as a proxy for affective disorders in public health surveys. It also has excellent discriminant validity.[@bib14] The questionnaire asks about being able to concentrate on what you are doing, losing sleep over worries, feeling that you are playing a useful part of things, feeling able to make decisions about things, feeling constantly under strain, feeling you cannot overcome your difficulties, being able to enjoy normal day to day activities, being able to face up problems, feeling unhappy or depressed, losing confidence in yourself, feeling worthless, and feeling reasonably happy when all things are considered. Each question ranged from 0 to 3 with 0 = less than usual, 1 = no more than usual, 2 = rather more than usual, and 3 = much more than usual, for a total possible score of 36. The GHQ marking scale (0:0:1:1) was used in this research to eliminate bias. A total cut off of 5--6 was scored as negative for psychopathology, and a score of 7 or more was positive for psychopathology. Questions 2, 5, 6, 9, 10, and 11 of the scale are marked in a negative way.

Demographic information, duration of diabetes, and diabetes medications were additional data collected.

A blood sample was taken for HbA1c measurement to assess the degree of glycaemic control using a glycol haemoglobin reagent set manufactured by HB1C Siemens Healthcare Diagnostics Newark, DE 19714, USA. The ethical committee of Omdurman Teaching Hospital approved the research and The Statistical Package for Social Sciences (SPSS version 16) was used for data analysis. The data variables were tested for normality of distribution and found to be normally distributed; therefore, t-test and Pearson correlation analysis were used to test the relationship between the variables. The data were presented as the mean ± SD or percentages, unless otherwise specified, with a P-value\< 0.05 considered significant.

Results {#sec3}
=======

Of the 89 diabetic patients enrolled in the study, 40.2% were males, their ages ranged from 38 to 82 years with a mean of 59.64 ± 9.60 years, and the duration of diabetes mellitus was 9.14 ± 8.1 years ([Table 1](#tbl1){ref-type="table"}).Table 1Characteristics of the study group.Table 1CharacterMean ± SD**Age** Mean ± SD59.64 ± 9.60Duration of diabetes9.14 ± 8.1**Sex** Males36 (40.4%) Females53 (59.6%)Psychopathology78.8%Diabetes distress score \> 387.6%

In the present study, nearly two-thirds of the participants were on sulphonylureas (59.1%). Additionally, 72.4% were taking metformin, while 8.9% were taking insulin. [Table 2](#tbl2){ref-type="table"} illustrates the drug therapy of the enrolled diabetic patients.Table 2Medications taken by the study groups.Table 2Drugn (%)Sulphonylureas Glibenclamide10 (11.4%) Glimepride38 (43.2%) Gliclazide4 (4.5%) Total52 (59.1%)Metformin64 (72.4%)Pionorm7 (8%)Insulin8 (8.9%)Statins48 (54.1%)Aspirin43 (47.7%)Amlodipine19 (21.8%)Losartan23 (26.1%)Bisoprolol4 (4.5%)

[Table 3](#tbl3){ref-type="table"} depicts the components of the diabetes distress scale in which the highest value was reported for feeling that I will end up with serious long-term complications no matter what I do (4.60 ± 1.40), followed by feeling overwhelmed by the demands of living with diabetes (4.33 ± 1.62) and feeling that I don\'t have a doctor who I can see regularly about my diabetes (3.87 ± 1.76). The lowest reported values were for feeling that friends or family don\'t give me the emotional support that I would like and feeling that friends or family don\'t appreciate how difficult living with diabetes can be (3.35 ± 2.19 and 3.39 ± 1.85, respectively) (see [Table 4](#tbl4){ref-type="table"}).Table 3The different components of the diabetes distress scale.Table 3CharacterMean ± SDFeeling that diabetes is taking too much of my physical and mental energy3.88 ± 1.38Feeling that my doctor doesn\'t know enough about diabetes and diabetes care3.71 ± 1.38Feeling angry, scared and/or depressed when I think about living with diabetes3.80 ± 1.40Feeling that my doctor doesn\'t give me clear enough directions on how to manage my diabetes3.64 ± 1.44Feeling that I am not testing my blood sugar frequently enough3.43 ± 1.30Feeling that I am often failing with my diabetes regimen3.51 ± 1.28Feeling that friends or family not supportive enough3.47 ± 1.63Feeling that diabetes controls my life3.92 ± 1.45Feeling that my doctor doesn\'t take my concerns seriously enough3.82 ± 1.40Not feeling confident in my day-to-day ability to manage diabetes3.58 ± 1.45Feeling that I will end up with serious long-term complications, no matter what I do4.60 ± 1.40Feeling that I am not sticking closely enough to good meal plan3.41 ± 1.40Feeling that friends or family don\'t appreciate how difficult living with diabetes can be3.39 ± 1.85Feeling overwhelmed by the demands of living with diabetes4.33 ± 1.62Feeling that I don\'t have a doctor who I can regularly see about my diabetes3.87 ± 1.76Not feeling motivated to keep up my diabetes self-management3.44 ± 1.93Feeling that friends or family don\'t give me the emotional support that I would like3.35 ± 2.19Table 4The general health questionnaire components among diabetic patients and control subjects.Table 4Parameter (Mean ± SD)DiabeticsControlP-value\*Being able to concentrate on what you are doing2.02 ± 0.801.96 ± 0.490.695Losing much sleep over worries1.43 ± 0.710.93 ± 0.450.001Feeling that you are playing useful part of things1.89 ± 0.481.82 ± 0.380.489Feeling able about making decisions about things1.95 ± 0.621.82 ± 0.380.308Feeling constantly under strain1.55 ± 0.751.06 ± 0.650.004Feeling you couldn\'t overcome your difficulties1.01 ± 0.620.75 ± 0.430.049Feeling able to enjoy your normal day to day activities2.18 ± 0.691.82 ± 0.530.014Feeling able to face up your problems2.05 ± 0.721.89 ± 0.480.275Feeling unhappy or depressed1.44 ± 0.790.93 ± 0.590.002Losing confidence in yourself0.92 ± 0.550.72 ± 0.450.083Feeling of yourself as a worthless person0.86 ± 0.530.82 ± 0.530.726Feeling reasonably happy all thing considered2.21 ± 0.741.75 ± 0.510.003Overall psychopathology score19.53 ± 5.0216.27 ± 3.530.002[^1]

Regarding the general health questionnaire components, no statistically significant difference was evident among patients with type 2 diabetes and control subjects in the ability to concentrate on what they are doing (2.02 ± 0.80 vs. 1.96 ± 0.49, P-value = 0.695). Diabetic patients were more likely to lose much sleep over worries, and this difference was statistically significant (1.43 ± 0.71 vs. 0.93 ± 0.45, P-value = 0.001). No differences were evident between patients and control subjects regarding the feeling that they are playing a useful part of things and the feeling of the ability to make decision about things (1.89 ± 0.48 vs. 1.82 ± 0.38 and 1.95 ± 0.62 vs. 1.82 ± 0.38, P-values = 0.489 and 0.308, respectively). Diabetic patients were more likely to feel constantly under strain, and this difference was statistically significant (1.55 ± 0.75 vs. 1.06 ± 0.65 P-value = 0.004). [Table 5](#tbl5){ref-type="table"} illustrates the other components of the general health questionnaire among patients with type 2 diabetes and control subjects.Table 5The correlation between HbA1c and age, duration of diabetes, diabetes distress domains and psychopathology.Table 5CharacterPearson correlationP-value\*Age0.0760.481Duration of diabetes0.1120.301Emotional domain0.2210.039Physician domain−0.0090.934Regimen domain0.3310.002Interpersonal domain−0.1290.232Total distress score0.1760.101Psychopathology total score0.0340.782[^2]

In the present study, no correlation was found between the glycated haemoglobin and age (Pearson correlation = 0.076, P-value = 0.481) or the duration of diabetes (Pearson correlation = 0.112, P-value = 301). A significant positive correlation was observed between the emotional and regimen-related domains of the diabetes distress scale and HbA1c level (Pearson correlation = 0.221 and 0.331, P-values = 0.039 and 0.002, respectively). A negative correlation was observed between the interpersonal and physician related domains and glycated haemoglobin level with no significant statistical difference (Pearson correlation = −0.129 and −0.009, P-value = 0.232 and 0.934, respectively). The current data show no correlation between the total diabetes-related distress or psychopathology scores and glycaemic control (Pearson correlation = 0.176 and −0.034, P-value = 0.101 and 0.782, respectively) ([Table 5](#tbl5){ref-type="table"}).

In the current study, statistically significant differences were found between males and females regarding the duration of diabetes (11.58 ± 9.9 vs. 7.46 ± 6.10, P-value = 0.018), but no significant differences were reported regarding age (58.97 ± 9.9 vs. 60.11 ± 9.4, P-value = 0.586) or HbA1c (9.86 ± 2.34 vs. 9.94 ± 2.87, P-value = 0.899). [Table 6](#tbl6){ref-type="table"} depicts the comparison between males and females.Table 6A comparison between males and females regarding age, duration of diabetes, diabetes distress domains and psychopathology and HbA1c.Table 6CharacterMaleFemaleP-value\*Age58.97 ± 9.960.11 ± 9.40.586Duration of diabetes11.58 ± 9.97.46 ± 6.100.018HbA1c9.86 ± 2.349.94 ± 2.870.899Emotional domain4.11 ± 0.744.11 ± 0.890.994Physician domain3.66 ± 1.083.85 ± 1.150.454Regimen domain3.52 ± 1.433.17 ± 1.430.266Interpersonal domain3.48 ± 0.833.41 ± 1.010.727Total distress score3.67 ± 0.583.66 ± 0.700.992Psychopathology total score19.44 ± 4.5120.07 ± 4.450.573[^3]

Discussion {#sec4}
==========

In the present study, diabetes distress was identified in 87.6% of patients with type 2 diabetes, which was higher than the results of a survey carried out in Malaysia[@bib8] in which diabetes distress was observed in 49.2% of patients. In mainland China,[@bib15] the prevalence of diabetes-related distress was 64%, which is lower than that in the present study. In the current survey, the highest score was reported for the fear of the diabetes complications and the demands of living with diabetes mellitus. It would be very difficult to compare the rate of diabetes distress reported in the current study and those reported in other countries because of the wide variations in age, gender, racial factors, measures used for diagnosis, and the scale of diabetes centres. There is some possibility of selection bias.

In the present study, psychopathology was evident in 78.8% of diabetic patients vs. 21.2% of healthy controls. This result is lower than that reported in Malaysia (41.7%) and the United States of America (17%).[@bib10], [@bib16] Racial factors and the different measures used to establish a diagnosis may explain the differences in the prevalence of diabetes distress and depression.[@bib7], [@bib17]

The current data show no relationship between age, gender, the duration of diabetes mellitus, diabetes-related distress score, or psychopathology and the level of glycaemic control (HbA1c). Similarly, researchers from Malaysia[@bib18] reported no correlation between age, sex, ethnicity, diabetes-related distress or psychopathology and glycaemic control. Our data differed from the data generated by studies conducted in India.[@bib19]

The previous literature[@bib20] reported that there was no relationship between depression and glycaemic control and suggested that any relationship to the depressive state had to be of sufficient duration and intensity to demonstrate an effect. Additionally, depression may affect glycaemic control by different pathways in different patients. In the present study, no relationship was evident between depression, as measured by the 12-items general health questionnaire, and glycated haemoglobin level, which supports the above observation.

In the present study, emotional burden was the most important domain in measuring diabetes distress (4.08 ± 0.88), followed by physician-related factors (3.75 ± 0.1.13). Both were in the range of a somewhat serious problem, and previous researchers have reported similar findings.[@bib21] Furthermore, the emotional burden and regimen-related domains were related to glycated haemoglobin, in line with previous literature[@bib22], [@bib23] that found that the emotional burden and regimen-related domains were a strong predictor of glycaemic control.

Previous studies concluded the following: the items of the emotional burden domain and the regimen related distress domain loaded on the same factor and correlated to HbA1c.[@bib12]

Interestingly, the current data show that the emotional domain had the highest value, followed by the physician-related domain. The interpersonal domain (representing the family and friends support) had the lowest value. Furthermore, the emotional- and regimen-related domains were associated with poor glycaemic control. The supportive extended Sudanese family can be over caring (as shown by the low interpersonal score), regularly supervising patients and asking them to take care of their diabetes, which places more pressure on them (high regimen score). This may increase the emotional domain, creating a vicious cycle marked by less glycaemic control and more microvascular complications.[@bib24], [@bib25] Family education is of paramount importance to reduce diabetes distress, as resilience and self-efficacy have been found to decrease diabetes distress, while empowerment substantially increases it.[@bib26] Behavioural intervention has shown promise in helping diabetic patients manage the emotional burden. A better understanding of how diabetes relates to distress and how earlier detection and appropriately timed support helps patients cope with diabetes[@bib23] is greatly needed.

The present study shows that diabetic patients feel that they will end up with serious long-term complications no matter what they do. Feeling that they do not have a doctor who they can see regularly about their diabetes and feeling overwhelmed by the demands of living with diabetes are the most important components pointing to the fact that patients are not well educated about diabetes complications. Their knowledge about strict glycaemic control and the microvascular complications of diabetes may also be weak. Furthermore, doctors are not available for patient follow-up, and laboratory tests and medications may be costly for the patients. The majority of Sudanese subsist under the absolute poverty line, with a low priority for expenditures on high health needs. The lack of organized diabetes care, shortage of well-trained staff in diabetes management and unavailability of social workers may add to the serious problem of diabetes distress and increase patient suffering.

In the present study, no statistically significant differences were found between women and men regarding age, HbA1, diabetes-related distress components, and psychopathology, while males tend to have diabetes for a longer period than females. A plausible explanation could be the small size of the study sample.

Conclusion {#sec5}
==========

Diabetes distress and psychopathology were both common among Sudanese patients with type 2 diabetes. The emotional burden and regimen-related domains of diabetes distress, but not psychopathology, were related to glycaemic control.

Recommendations {#sec6}
===============

Larger multicentre studies are needed to examine the effects of the different components of diabetes distress on the glycated haemoglobin, diabetes self-management, and medication adherence.

The study is limited by the small size of the survey sample and the fact that it was conducted at a single diabetes centre. For these reasons, generalization cannot be ensured. Additionally, we did not report significant factors such as the level of education or marital status, which may substantially affect diabetes distress. The unmatched number of control subjects and diabetic patients may also have affected the result.
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